✦ LIBER ✦

Prediction of the Need for Red Cell Transfusion in Newly Diagnosed Ovarian Cancer Patients Undergoing Platinum-Based Treatment

✍ Scribed by David Heddens; David S. Alberts; Edward V. Hannigan; Steven D. Williams; Dava Garcia; Denise J. Roe; Jeffrey Bell; Ronald D. Alvarez

Book ID: 112251880
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 43 KB
Volume: 86
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.2002.6726

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ERCC1-Positive Circulating Tumor Cells i

ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance

✍ Kuhlmann, J. D.; Wimberger, P.; Bankfalvi, A.; Keller, T.; Scholer, S.; Aktas, B 📂 Article 📅 2014 🏛 American Association for Clinical Chemistry 🌐 English ⚖ 244 KB

Integration of autologous dendritic cell

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

✍ Hilko Ardon; Stefaan Van Gool; Isabel Spencer Lopes; Wim Maes; Raf Sciot; Guido 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 349 KB

Integration of autologous dendritic cell

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

✍ Hilko Ardon, Stefaan W. Van Gool, Tina Verschuere, Wim Maes, Steffen Fieuws, Raf 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 353 KB

PCN11 COMPARING THE PROVIDER TIME AND CO

PCN11 COMPARING THE PROVIDER TIME AND COSTS FOR RED BLOOD CELL TRANSFUSIONS IN ANAEMIA MANAGEMENT OF CANCER PATIENTS USING THE ACTIVITY-BASED COSTING (ABC) METHOD IN A FRENCH AND AUSTRIAN SETTING

✍ L Van Bellinghen; E De Cock; P Piedbois; P Sevelda; F Sevelda 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

The safety and efficacy of gefitinib ver

The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: A meta-analysis

✍ Chang, Chia-Hsuin; Chen, Kuan-Yu; Young-Xu, Yinong; Kurth, Tobias; Orav, E. John 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 362 KB

P-488 Phase II randomized trial of singl

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

✍ Gridelli, C.; Reck, M.; Gregorc, V.; Migliorino, M.; Muller, T.; Manegold, C.; F 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB